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Table S1. Antibodies used for immunocytochemistry (ICC) and immunohistochemistry 
(IHC) (Ms§: mouse antibody; Rb*: rabbit antibody) 
 
Antibody Antigen retrieval Source Dilution 
BLBP (ICC, IHC), Rb* citrate buffer (pH=6.0) Chemicon, Temecula CA 1:1000 
APC (CC1) (IHC), Ms§ citrate buffer (pH=6.0) Calbiochem, San Diego CA 1:50 
Clusterin(IHC), Rb citrate buffer (pH=6.0) Santa Cruz,  Santa Cruz CA 1:100 
Cre (IHC), Ms citrate buffer (pH=6.0) Novagen, Madison WI 1:10000 
GFAP (ICC), Rb none Sigma, St Louis MO 1:500 
GFAP (IHC), Rat 1 mM EDTA (pH=8.0) Zymed, San Francisco CA 1:200 
GFP (IHC), Rb citrate buffer (pH=6.0) Abcam, Cambridge MA 1:2500 
Nestin (ICC), Ms none Calbiochem 1:100 
NeuN (IHC), Ms citrate buffer (pH=6.0) Chemicon 1:250 
NG2 (IHC), Rb 1 mM EDTA Chemicon 1:100 
O4 (ICC), Ms (IgM) none Chemicon 1:1000 
Olig2 (ICC, IHC), Rb citrate buffer (pH=6.0) Charles D. Stiles (Dana Farber) 1:10000 
PDGFR-α (IHC), Rat citrate buffer (pH=6.0) BD Pharmingen, Franklin Lakes NJ 1:100 
Tuj-1 (ICC), Ms none Covance, Berkeley CA 1:1000 
WT-1 (IHC), Rb citrate buffer (pH=6.0) Abcam 1:100 
Table S2. Antibodies used for Western blotting (Ms§: mouse antibody; Rb*: rabbit antibody) 
Antibody Host Source Dilution 
4EBP1 Rb* Cell Signaling , Denver MA 1:1000 
Akt Rb Cell Signaling 1:1000 
Cre Ms§ Covance 1:10000 
FoxO1 Rb Cell Signaling 1:1000 
GSK3-β Rb Cell Signaling 1:1000 
H-Ras Rb Santa Cruz 1:200 
K-Ras Rb Santa Cruz 1:200 
MAPK Rb Cell Signaling 1:1000 
Neurofibromin Rb Santa Cruz 1:250 
N-Ras Ms Santa Cruz 1:200 
p120-GAP Ms BD Transduction Laboratory 1:2000 
p27 Rb Cell Signaling 1:1000 
p68 Rb Jason D. Weber (Washington University School of Medicine)  1:10000 
phospho-4EBP1 Rb Cell Signaling 1:1000 
phospho-Akt Rb Cell Signaling 1:1000 
phospho-FoxO1 Rb Cell Signaling 1:1000 
phospho-GSK-3β Rb Cell Signaling 1:1000 
phospho-MAPK Rb Cell Signaling 1:1000 
phospho-p27 (Ser10) Rb Zymed 1:200 
phospho-p27 (T198) Rb Abcam 1:1000 
phospho-PDK1 Rb Cell Signaling 1:1000 
phospho-PKCα Rb Cell Signaling 1:1000 
phospho-S6 Rb Cell Signaling 1:1000 
phospho-S6 Kinase Rb Cell Signaling 1:1000 
phospho-STAT3 Rb Cell Signaling 1:1000 
PKCα Rb Cell Signaling 1:1000 
PTEN Rb Cell Signaling 1:1000 
Raptor Rb Bethyl Laboratories, Montgomery TX 1:1000 
Rictor Rb Bethyl Laboratories 1:1000 
S6 Rb Cell Signaling 1:1000 
 S6 Kinase Rb Cell Signaling 1:1000 
STAT3 Rb Cell Signaling 1:1000 
pan Ras Ms Upstate Biotech, Billerica MA 1:10000 
α-tubulin Ms Sigma 1:10000 
 Table S3. Primers used for real-time quantitative RT-PCR 
 
 
Gene Accession # Forward primer Reverse primer 
Ppp2r2b NM_028392 5'- ATGGAATGGGTCAGACAGCG-3' 5'- GGCCTCAAGGGTCACATCAC-3' 
Prkce NM_011104 5'- CACCAGCACGGAGTGATCTACA-3' 5'- CCTTGCACATCCCAAAGTCAG-3' 
Prkcq NM_008859 5'- ATGCATGTGGCATGAACGTC-3' 5'- ATCATCGCTAGTGCTTCAGCC-3' 
Rasal2 NM_177644 5'- ACAGGAAAAGCGGATCGTGT-3' 5'- ATTGCGGACCTGCATGCT-3' 
Rasgrp1 NM_011246 5'- ATCTTTTGATGCGGATGGAAA-3' 5'- TAGCAGCTCGGCTGAGGAG-3' 
Tenc1 NM_153533 5'- GGCTGATGAGCGGTTTCCT-3' 5'- AGAGGGATCATTCCGTGGG-3' 
Actb NM_007393 5'-ACTATTGGCAACGAGCGGTT-3' 5'-ATGCCACAGGATTCCATACCC-3' 
 Supplemental Experimental Procedures 
 
Sectioning of neurospheres for immunocytochemistry. Neurospheres were fixed in 4% 
paraformaldehyde for 30 min followed by washing twice in PBS. Neurospheres were 
cryoprotected with 30% w/v sucrose solution for 3-4 hr (von Holst et al., 2006). Fixed 
neurospheres were embedded in freezing medium and sectioned at 16 µm.  
Multi-lineage differentiation assay.  Neurospheres were trypsinized and plated onto 24 well 
plates coated with poly-D-lysine (50 µg/ml) and fibronectin (10 µg/ml) with NSC medium without 
growth factors. After 6 days, the cells were fixed with 4% paraformaldehyde. For optic nerve 
(ON) neurospheres, single neurospheres were plated onto poly-D-lysine- and fibronectin- 
coated plates without trypsinization.  
Ras activity assay. The levels of GTP-bound active Ras were measured by Raf1-RBD affinity 
chromatography using the Ras activity assay kit (Upstate Biotechnology, Lake Placid, NY) 
according to the manufacturer’s instructions. Briefly, 150 µg of protein was incubated with 
agarose beads conjugated with Raf1-RBD for 50 min at 4°C. Raf1-RBD bound Ras isoforms 
were detected by Western blotting using anti-K-, H- and N-Ras isoform-specific antibodies.  
Measurement of NSC self-renewal and proliferation. At least 10 neurospheres from each 
genotype were trypsinized and plated into individual wells of ultra-low binding 24 well plates with 
complete NSC medium containing EGF and FGF. After 12-14 days, NSC self-renewal was 
assessed by counting the number of resulting secondary neurospheres. Supplements were 
added every 3 days. To measure NSC proliferation over several passages, 5000 cells from 
each genotype beginning at passage 3 were plated into individual wells. Resulting 
neurospheres were trypsinized and cell number was counted at day 6. This procedure was 
repeated for a total of three passages. 
 Real-time quantitative reverse transcription-PCR (qRT-PCR). Real-time qRT-PCR was 
performed as previously described (Yeh et al., 2009) using the primers listed in Table S3. β-
actin was used as an internal control. For each gene, the ∆∆CT values were calculated for each 
gene from at least three independently-generated PN1 NSC cultures.   
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Fig. S1. Characterization of NSC cultures from different brain regions. (A) Neurospheres 
generated from the CTX or BS of PN1 mice were positive for BLBP and nestin expression. Cells 
were counterstained with DAPI. Quantification of the size (B) and the number (C) of secondary 
neurospheres generated from single neurospheres from the neocortex (CTX), brainstem (BS) 
and optic nerve (ON) shows that NSCs from different brain regions exhibit different levels of 
self-renewal and proliferation. (D) Multi-lineage differentiation of ON neurospheres revealed that 
most of the cells differentiated into GFAP+ astrocytes, but not Tuj-1+ neurons or O4+ 
oligodendrocytes. (E) Multi-lineage differentiation of PN1 NSCs from the CTX and BS is shown. 
Immunocytochemistry with Tuj-1 (neuron), GFAP (astrocyte) and O4 (oligodendrocyte) 
antibodies shows that PN1 NSCs from both the CTX and BS can differentiate into these three 
different types of brain cells. Scale bar: 100 µm. 
 
Fig. S2. Increased proliferation in BS NSCs was observed following Nf1 gene inactivation. 
(A) Direct cell counting over several passages shows increased proliferation of NSCs only from 
the BS, but not the CTX, following Nf1 inactivation. Nf1 gene inactivation was confirmed by 
Western blotting (top). (B) No change in self-renewal was observed in Nf1-/- NSCs compared to 
WT NSCs. (C) Direct cell counting revealed a 1.4-fold increase in PN1 SVZ NSC proliferation 
relative to WT NSCs. (D) The number of Ki67+ cells in the SVZ of PN8 Nf1BLBPCKO mice was 
increased by 1.3-fold compared to WT control littermates. (E) Loss of neurofibromin following 
Cre expression was confirmed by Cre immunohistochemistry using an anti-Cre antibody (left) 
and neurofibromin western blotting (right) in both the CTX and the BS of PN18 Nf1BLBPCKO 
mice. Scale bar: 100 µm. Values represent mean ±SEM.  *p<0.05, **p<0.01. 
  
 
Fig. S3. Olig2+ cells are increased in the brainstem following Nf1 loss. (A) The number of 
Olig2+ cells was increased by 2.2-fold in PN1 BS NSCs following Nf1 inactivation compared to 
1.4-fold in PN1 SVZ NSCs. (B) The number of Olig2+ cells was increased by 2.7-fold in 
embryonic (E16) BS NSCs following Nf1 inactivation compared to 1.3-fold in E16 CTX NSCs. 
(C) Double immunofluorescence immunocytochemistry for APC (CC1) and Olig2 shows that 
while the number of Olig2+ (red) cells was increased following Nf1 inactivation in the BS, there 
was no change in the number of APC/Olig2 double positive (yellow) cells. (D) The majority of 
the Olig2+ cells in the CTX and BS of PN8 Nf1BLBPCKO mice were not positive for PDGFR-α. 
(E) Fewer than 5% of the Olig2+ cells were O4+ following in vitro differentiation of Nf1-deficient 
CTX (3.8%) and BS (4.0%) NSCs. (F) The number of NG2+ cells was increased in both CTX 
(1.5-fold) and BS (1.6-fold) of Nf1BLBPCKO mice compared to WT controls. (G) No change in the 
number of GFAP+ cells was observed in the SVZ of Nf1BLBPCKO mice compared to WT controls. 
Scale bar: (C, E, G), 100 µm; (D), 50 µm. Values represent mean ±SEM. *p<0.05, **p<0.01, 
p***<0.0001.  
 
Fig. S4. Nf1 loss affects only astroglial lineage differentiation in vivo. The number of WT-1- 
(A) and clusterin- (B) positive astrocytes was increased in the BS of PN18 Nf1BLBPCKO mice 
compared to wild-type (WT) controls. No changes in astrocyte cell numbers (WT-1+ or 
clusterin+ cells) were observed in the CTX following Nf1 inactivation. (C) NeuN 
immunohistochemistry demonstrates that Nf1 loss does not change the number of NeuN+ 
neurons in the PN18 Nf1BLBPCKO mouse brain. (D) There was also no difference in the number 
of APC+ oligodendrocytes between PN18 WT and Nf1BLBPCKO brains. Scale bar: 100 µm. 
Values represent mean ±SEM.  *p<0.05. 
 
  
 
Fig. S5. Ras transgene expression and activation. (A) Nf1-/- embryonic (E11.5) NSCs exhibit 
increased levels of GTP-bound (activated) K-Ras, H-Ras, and N-Ras relative to WT NSC 
cultures. For positive (+) and negative (-) controls, cell lysates were incubated with 100 µM 
GTPγS and 1 mM GDP, respectively. (B) GTP-bound activated Ras was increased in BLBP-
Cre; LSL-K-RasG12D (KRas*) mouse brain tissues relative to WT brains. (C) Expression of 
constitutively-active H-Ras was confirmed by Western blotting in MSCV-H-RasG12V-GFP 
(HRas*)-infected NSC cultures. (D) Expression of constitutively-active K-Ras was detected 
using a Ras activity assay followed by Western blotting with anti-K-Ras antibody in K-RasG12D 
(KRas*)-expressing NSCs. 
  
Fig. S6. Neurofibromin loss in BS and CTX NSCs has no effect on the expression of 
upstream Ras and Akt regulators or mTOR downstream effectors. (A) mRNA expression 
levels of Ppp2r2b (protein phosphatase 2), Prkce (PKCε), Prkcq (PKCθ), Tenc1 (C1-TEN), 
Rasal2 (Ras protein activator like 2) and Rasgrp1 (Ras-GRP) as measured by qRT-PCR are 
equivalently expressed in WT (LacZ) and Nf1-/- (Cre) NSCs. There were no regional differences 
in the ratios of mRNA expression (KO/WT) of these regulators between CTX (white bars) and 
BS (black bars). (B) No change in the activation status of PKCα, S6K, S6 and 4EBP1 was 
observed in Nf1-/- NSCs. In contrast, Akt activation was seen following neurofibromin loss in 
brainstem (BS), but not in cortex (CTX), NSCs. Values represent mean ±SEM.  
